{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:26:32Z","timestamp":1758122792451},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1016\/s0301-2115(01)00580-2","type":"journal-article","created":{"date-parts":[[2002,10,14]],"date-time":"2002-10-14T15:56:01Z","timestamp":1034610961000},"page":"179-183","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of GnRH agonists and antagonists in unselected IVF\/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study"],"prefix":"10.1016","volume":"102","author":[{"given":"Juan C.Barros","family":"Del Gadillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Siebzehnr\u00fcbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0301-2115(01)00580-2_BIB1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/oxfordjournals.humrep.a137105","article-title":"The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyperstimulation for in vitro fertilization and embryo transfer","volume":"5","author":"Loumaye","year":"1990","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loo in polycystic ovary syndrome","volume":"297","author":"Homburg","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.humrep.a138030","article-title":"Comparative trial between an ultra-short and -long protocol of luteinizing-releasing hormone agonist for ovarian stimulation in in vitro fertilization","volume":"8","author":"Marcus","year":"1993","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB4","unstructured":"Deutsches IVF Register Jahrbuch, 1998."},{"issue":"Suppl. 1","key":"10.1016\/S0301-2115(01)00580-2_BIB5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/humrep\/7.suppl_1.49","article-title":"The use of gonadotropin-releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with hMG: results of prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix\u00ae and the LH-RH agonist buserelin","volume":"15","author":"Albano","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/humrep\/15.5.1015","article-title":"Ovarian stimulation for assisted reproduction with hMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix\u00ae according to the multiple dose protocol: a prospective uncontrolled phase III study","volume":"15","author":"Felberbaum","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/oxfordjournals.humrep.a136219","article-title":"Development and applications of luteinizing hormone-releasing hormone agonists in the treatment of infertility: an overview","volume":"10","author":"Reissman","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(16)56932-5","article-title":"A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix\u00ae) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge","volume":"62","author":"Leroy","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/oxfordjournals.humrep.a137773","article-title":"Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotropin-releasing hormone antagonist (Nal-Glu) during the late follicular phase","volume":"7","author":"Frydman","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB11","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/0002-9378(91)90037-R","article-title":"The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women","volume":"165","author":"Ditkoff","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","article-title":"Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix\u00ae during ovarian stimulation","volume":"9","author":"Diedrich","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix\u00ae in an in vitro fertilization embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil. Steril."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB14","first-page":"1382","article-title":"Scheduled administration of a gonadotropin-releasing hormone antagonist (Cetrorelix\u00ae) on day 8 in vitro fertilization cycles: a pilot study","volume":"10","author":"Olivennes","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02065939","article-title":"Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin-releasing hormone (GnRH) antagonist Cetrorelix\u00ae at different dosages","volume":"13","author":"Felberbaum","year":"1996","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/oxfordjournals.humrep.a019058","article-title":"Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotropin and gonadotropin-releasing hormone antagonist (Cetrorelix\u00ae)","volume":"11","author":"Albano","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix\u00ae during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB18","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/13.9.2411","article-title":"The use of a GnRH antagonist (Cetrorelix\u00ae) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg","volume":"13","author":"Olivennes","year":"1998","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB19","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/humrep\/14.12.2959","article-title":"Will GnRH antagonists provide new hope for patients considered difficult responders to GnRH agonist protocol?","volume":"14","author":"Craft","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB20","first-page":"249","article-title":"LH-RH antagonist protocols in IVF do not lead to worse results than the long LH-RH agonist protocol","volume":"7","author":"Ludwig","year":"2000","journal-title":"Ref. Gynecol. Obstet."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/oxfordjournals.humrep.a137800","article-title":"The effect of gonadotropin-releasing hormone (GnRH) agonist in the follicular phase on in vitro fertilization outcome in normo-ovulatory women","volume":"7","author":"Smitz","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0301-2115(95)02138-W","article-title":"Preserved pituitary response under ovarian stimulation with hMG and GnRH antagonists (Cetrorelix\u00ae) in women with tubal infertility","volume":"61","author":"Felberbaum","year":"1995","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LH-RH antagonist Cetrorelix\u00ae (Cetrotide\u00ae) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Arch. Gynecol. Obset."},{"key":"10.1016\/S0301-2115(01)00580-2_BIB24","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","volume":"15","author":"Iskovitz-Eldor","year":"2000","journal-title":"Hum. Reprod."}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211501005802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211501005802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:57:26Z","timestamp":1556899046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211501005802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0301211501005802"],"URL":"https:\/\/doi.org\/10.1016\/s0301-2115(01)00580-2","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}